CClinicalTrials.gg
CompletedNCT07632781Updated Jun 8, 2026

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSİVE CARE PATIENTS UNDER MECHANICVENTILATION SUPPORT

An interventional study of su jok therapy group and Placebo Group in Intensive Care Unit Patients, sponsored by Hasan Kalyoncu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Hasan Kalyoncu University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Mar 2025, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to examine the effect of Su Jok Therapy, applied to patients receiving mechanical ventilation support in the intensive care unit, on pain and physiological parameters.

Read the detailed description

Mechanical ventilation (MV), one of the most common treatment methods in Intensive Care Units (ICUs), is a critical treatment approach to ensure adequate respiratory function in patients.

Although mechanical ventilation is a life-saving treatment method in ICUs, it can cause many physiological and psychological problems for patients. Furthermore, excessive exposure to physical, psychosocial, and environmental stressors can affect the patient's autonomic response and vital parameters (tachycardia, hypertension, tachypnea), leading to hemodynamic instability

The World Health Organization (WHO) defines Integrated, Complementary, and Alternative Medicine Practices as the provision of healthcare services that are not part of a country's own tradition or conventional medicine and are not fully integrated into the dominant healthcare system In intensive care patients, non-pharmacological methods such as aromatherapy, music therapy, massage, reflexology, acupressure, and Reiki are used as complementary and alternative treatments. Su Jok, one of these non-pharmacological methods, is an alternative treatment method based on traditional Korean medicine. Su Jok is a treatment method that uses the feet and hands, derived from the Korean words Su (hand) and Jok (foot). In the literature, it is argued that nurses can apply Su Jok therapy as an integrative method in symptom management due to its simplicity of application, lack of side effects, and non-invasiveness, which is similar to the philosophy of integrative nursing. Looking at the literature, very few studies on Su Jok therapy have been found. No studies have been found in the literature regarding the effect of Su Jok therapy on intensive care patients and patients on mechanical ventilation support.

02

Conditions studied

  • Intensive Care Unit Patients

Browse trials for

Keywords

  • SU-JOK THERAPY
  • Intensive Care Unit
  • pain
  • PHYSIOLOGICAL PARAMETERS
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's enrollment of 30 is below the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Hasan Kalyoncu University is the lead sponsor of 161 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who are in intensive care,

    • Patients receiving IMV support,
    • Patients who were admitted to the ICU from the start date of the study and are planned to be monitored for at least 24 hours,
    • Patients without any problems in the area where Su-Jok will be applied,
    • Patients with GCS > 3, RASS between +1 and +4, BPS > 3

Exclusion criteria

Exclusion Criteria:

    • Patients in the ward,

      • Patients with any problems such as fungal infections or wounds in the area where Su Jok will be applied,
      • Patients with a GCS of 3,
      • Patients not receiving IMV support will not be included in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Intervetion group

    In the intervention group, su-jok seed therapy will be applied to the su-jok reflection zones on the hands.

    Other: su jok therapy group

  • Placebo comparator
    Placebo group

    In the placebo group, su-jok seed therapy will be applied to areas on the hands that are different from the reflection zones.

    Other: Placebo Group

  • No intervention
    Control group

    No intervention will be applied to the control group.

Interventions

  • Othersu jok therapy group

    In the intervention group, the reflex zones on the hands were identified with a probe. Buckwheat seeds were fixed to these areas with adhesive tape and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

  • OtherPlacebo Group

    In the placebo group, reflex zones on the hand were identified using a probe. Buckwheat seeds were fixed to a different area near these zones with a seed patch and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

06

What researchers measure

Primary outcomes

  1. Systolic Blood Pressure

    Hemodynamic response measured by systolic blood pressure

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  2. Heart Rate (Pulse Rate)

    Heart rate measured in beats per minute

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  3. Oxygen Saturation (SpO₂)

    Peripheral oxygen saturation

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  4. Body Temperature

    Core body temperature

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  5. Respiratory Rate

    Number of breaths per minute

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  6. Richmond Agitation-Sedation Scale (RASS)

    Negative scores indicate sedation, positive scores indicate agitation

    Time frame: baseline, 1 hour, 4 hours after intervention

  7. Behavioral Pain Scale (BPS)

    Higher scores indicate more severe pain

    Time frame: baseline, 1 hour, 4 hours after intervention

Secondary outcomes

  1. Hemodynamic Stability Index (Systolic/Diastolic Blood Pressure Change)

    Change in systolic and diastolic blood pressure from baseline to post-intervention measurements.

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  2. Oxygenation Trend (SpO₂ Change Over Time)

    hanges in peripheral oxygen saturation over the intervention period.

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  3. Heart Rate Variability (Clinical Pulse Trend)

    Changes in heart rate measured in beats per minute during and after intervention.

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  4. Sedation-Agitation Level Stability (RASS Trend)

    Changes in Richmond Agitation-Sedation Scale (RASS) scores over time indicating sedation or agitation level.

    Time frame: baseline, 1 hour, 4 hours after intervention

  5. Pain Intensity Change (Behavioral Pain Scale Trend)

    Changes in Behavioral Pain Scale (BPS) scores indicating pain severity over time.

    Time frame: baseline, 1 hour, 4 hours after intervention

  6. Respiratory Stability (Respiratory Rate Change)

    Changes in respiratory rate indicating respiratory stability during intervention.

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  7. Temperature Stability

    hanges in body temperature over time following intervention.

    Time frame: baseline, 15 minutes, 60 minutes, 4 hours after intervention

  8. Non-pharmacological Intervention Effectiveness (Overall Clinical Stability Score)

    Composite assessment of physiological stability based on vital signs and sedation/pain scores.

    Time frame: baseline, 4 hours after intervention

07

Study locations

1 site
  • Kahramanmaraş
    Kahramanmaraş, Kahramanmaraş 46050, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07632781
Lead sponsor
Hasan Kalyoncu University
Responsible party
MELTEM KALAYCI (PhD Student, Hasan Kalyoncu University) — Principal investigator
First posted
Jun 8, 2026
Start date
Mar 1, 2025
Primary completion
Mar 1, 2025
Completion
Nov 1, 2025
Last update
Jun 8, 2026

Study contacts

NERMİN OLGUN, Prof. Dr.
study chair · Hasan Kalyoncu University
MELTEM KALAYCI
principal investigator · Hasan Kalyoncu University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion